Selecta Biosciences Inc. (SELB) NASDAQ
$0.88 (0.08) (-8.00%)
Market Cap: $136.77M
As of 11/13/23 04:00 PM EST. Market closed.
Selecta Biosciences Inc. (SELB)
NASDAQ
$0.88
(0.08) (-8.00%)
Market Cap: $136.77M
As of 11/13/23 04:00 PM EST. Market closed.
selecta biosciences, inc. is a clinical-stage biopharmaceutical company that is focused on unlocking the full potential of biologic therapies by mitigating unwanted immune responses. selecta plans to combine its tolerogenic synthetic vaccine particles (svp™) to a range of biologics for rare and serious diseases that require new treatment options. the company’s current proprietary pipeline ... read more
selecta biosciences, inc. is a clinical-stage biopharmaceutical company that is focused on unlocking the full potential of biologic therapies by mitigating unwanted immune responses. selecta plans to combine its tolerogenic synthetic vaccine particles (svp™) to a range of biologics for rare and serious diseases that require new treatment options. the company’s current proprietary pipeline includes svp-enabled enzyme, oncology and gene therapies. sel-212, the company’s lead candidate in phase 2, is being developed to treat severe gout patients and resolve their debilitating symptoms, including flares and gouty arthritis. selecta’s sel-403 product candidate, a combination therapy consisting of svp-rapamycin and lmb-100, recently entered a phase 1 trial in 2018 for the treatment of patients with malignant pleural or peritoneal mesothelioma. selecta’s proprietary gene therapy product candidates are being developed for rare inborn errors of metabolism and have the potential to enable repeat read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
SPRINGER TIMOTHY A | Director | Mar 18, 2024 | Buy | $0.61 | 800 | 488 | 104,818 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Feb 07, 2024 | Buy | $0.66 | 2,400 | 1,575 | 90,418 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 15, 2024 | Buy | $0.56 | 1,200 | 672 | 104,018 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Feb 06, 2024 | Buy | $0.65 | 800 | 520 | 88,018 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 14, 2024 | Buy | $0.53 | 2,000 | 1,061 | 102,818 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Jan 17, 2024 | Buy | $0.69 | 800 | 552 | 87,218 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 13, 2024 | Buy | $0.58 | 3,200 | 1,868 | 100,818 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 12, 2024 | Buy | $0.61 | 1,200 | 735 | 97,618 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 11, 2024 | Buy | $0.65 | 1,200 | 785 | 96,418 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 08, 2024 | Buy | $0.66 | 4,800 | 3,187 | 95,218 | Mar 28, 2024, 05:11 PM |
SPRINGER TIMOTHY A | Director | Mar 26, 2024 | Option Exercise | $1.46 | 1,970,443 | 2,876,847 | 33,043,849 | Mar 26, 2024, 04:32 PM |
SPRINGER TIMOTHY A | Director | Mar 18, 2024 | Buy | $0.60 | 19,044 | 11,398 | 31,073,406 | Mar 20, 2024, 05:09 PM |
SPRINGER TIMOTHY A | Director | Mar 14, 2024 | Buy | $0.54 | 648,372 | 351,677 | 30,516,862 | Mar 18, 2024, 05:29 PM |
SPRINGER TIMOTHY A | Director | Mar 15, 2024 | Buy | $0.59 | 537,500 | 314,545 | 31,054,362 | Mar 18, 2024, 05:29 PM |
Brunn Carsten | President and CEO | Nov 13, 2023 | Option Exercise | $2.06 | 521,125 | 1,073,517 | 728,081 | Nov 15, 2023, 05:26 PM |
SPRINGER TIMOTHY A | Director | Nov 15, 2023 | Option Exercise | $403.47 | 123,925 | 49,999,835 | 123,925 | Nov 15, 2023, 05:20 PM |
SPRINGER TIMOTHY A | Director | Nov 15, 2023 | Option Exercise | $403.47 | 24,785 | 9,999,967 | 24,785 | Nov 15, 2023, 05:20 PM |
Brunn Carsten | President and CEO | Sep 25, 2023 | Sale | $1.06 | 2,932 | 3,108 | 783,081 | Sep 26, 2023, 06:01 PM |
TRABER PETER G | Chief Medical Officer | Sep 25, 2023 | Sale | $1.06 | 705 | 747 | 451,826 | Sep 26, 2023, 06:00 PM |
Brunn Carsten | President and CEO | Jan 04, 2023 | Sale | $1.13 | 27,597 | 31,287 | 799,534 | Jan 06, 2023, 05:16 PM |
Brunn Carsten | President and CEO | Jan 05, 2023 | Sale | $1.13 | 13,473 | 15,214 | 786,090 | Jan 06, 2023, 05:16 PM |
Johnston Lloyd P. | Chief Operations Officer | Jan 04, 2023 | Sale | $1.13 | 6,392 | 7,247 | 268,918 | Jan 06, 2023, 05:16 PM |
Johnston Lloyd P. | Chief Operations Officer | Jan 05, 2023 | Sale | $1.13 | 3,392 | 3,830 | 265,535 | Jan 06, 2023, 05:16 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Jan 05, 2023 | Sale | $1.13 | 3,392 | 3,830 | 364,336 | Jan 06, 2023, 05:15 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Jan 04, 2023 | Sale | $1.13 | 6,392 | 7,247 | 367,719 | Jan 06, 2023, 05:15 PM |
TRABER PETER G | Chief Medical Officer | Jan 05, 2023 | Sale | $1.13 | 3,465 | 3,913 | 446,141 | Jan 06, 2023, 05:15 PM |
TRABER PETER G | Chief Medical Officer | Jan 04, 2023 | Sale | $1.13 | 8,179 | 9,273 | 449,601 | Jan 06, 2023, 05:15 PM |
Brunn Carsten | President and CEO | Dec 05, 2022 | Sale | $1.33 | 4,522 | 6,014 | 544,283 | Dec 07, 2022, 04:17 PM |
Brunn Carsten | President and CEO | Sep 28, 2022 | Sale | $1.66 | 2,692 | 4,470 | 537,867 | Sep 30, 2022, 07:37 PM |
Brunn Carsten | President and CEO | Sep 02, 2022 | Sale | $1.85 | 4,768 | 8,810 | 540,559 | Sep 06, 2022, 08:37 PM |
COX CARRIE SMITH | Director | Jun 13, 2022 | Buy | $1.15 | 130,000 | 149,799 | 212,881 | Jun 15, 2022, 04:16 PM |
BARABE TIMOTHY C | Director | May 09, 2022 | Buy | $0.77 | 50,000 | 38,720 | 250,013 | May 11, 2022, 04:21 PM |
BARABE TIMOTHY C | Director | Jan 14, 2022 | Option Exercise | $2.10 | 10,000 | 21,000 | 200,013 | Jan 18, 2022, 04:19 PM |
TRABER PETER G | Chief Medical Officer | Jan 05, 2022 | Sale | $3.09 | 3,226 | 9,955 | 251,355 | Jan 07, 2022, 04:18 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Jan 05, 2022 | Sale | $3.09 | 3,416 | 10,541 | 268,353 | Jan 07, 2022, 04:18 PM |
Johnston Lloyd P. | Chief Operations Officer | Jan 05, 2022 | Sale | $3.09 | 3,416 | 10,541 | 175,299 | Jan 07, 2022, 04:18 PM |
Brunn Carsten | President and CEO | Jan 05, 2022 | Sale | $3.09 | 13,597 | 41,959 | 517,958 | Jan 07, 2022, 04:17 PM |
SPRINGER TIMOTHY A | Director | Dec 15, 2021 | Buy | $2.99 | 211,190 | 631,099 | 23,186,890 | Dec 17, 2021, 04:36 PM |
TRABER PETER G | Chief Medical Officer | Dec 10, 2021 | Sale | $2.99 | 4,083 | 12,196 | 164,381 | Dec 14, 2021, 05:17 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Dec 10, 2021 | Sale | $2.99 | 4,370 | 13,053 | 199,769 | Dec 14, 2021, 05:16 PM |
Johnston Lloyd P. | Chief Operations Officer | Dec 10, 2021 | Sale | $2.99 | 4,370 | 13,053 | 106,715 | Dec 14, 2021, 05:16 PM |
Brunn Carsten | President and CEO | Dec 10, 2021 | Sale | $2.99 | 17,196 | 51,363 | 305,255 | Dec 14, 2021, 05:16 PM |
SPRINGER TIMOTHY A | Director | Dec 13, 2021 | Buy | $2.98 | 14,592 | 43,491 | 22,975,700 | Dec 13, 2021, 05:16 PM |
SPRINGER TIMOTHY A | Director | Dec 10, 2021 | Buy | $2.99 | 58,681 | 175,439 | 22,961,108 | Dec 13, 2021, 05:16 PM |
SPRINGER TIMOTHY A | Director | Dec 09, 2021 | Buy | $3.06 | 3,748,000 | 11,468,880 | 22,902,427 | Dec 13, 2021, 05:16 PM |
Tan Kevin | Chief Financial Officer | Dec 02, 2021 | Buy | $3.03 | 5,000 | 15,127 | 5,000 | Dec 06, 2021, 04:25 PM |
DeSilva Nishan M | Director | Dec 02, 2021 | Buy | $2.96 | 7,000 | 20,723 | 7,000 | Dec 06, 2021, 04:25 PM |
COX CARRIE SMITH | Director | Dec 03, 2021 | Buy | $2.95 | 17,200 | 50,664 | 82,881 | Dec 06, 2021, 04:25 PM |
Brunn Carsten | President and CEO | Dec 02, 2021 | Sale | $2.96 | 4,746 | 14,065 | 284,951 | Dec 03, 2021, 04:28 PM |
TRABER PETER G | Chief Medical Officer | Oct 13, 2021 | Sale | $4.39 | 3,636 | 15,962 | 154,714 | Oct 15, 2021, 06:08 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Oct 13, 2021 | Sale | $4.39 | 3,892 | 17,086 | 190,389 | Oct 15, 2021, 06:07 PM |
Johnston Lloyd P. | Chief Operations Officer | Oct 13, 2021 | Sale | $4.39 | 3,892 | 17,086 | 97,335 | Oct 15, 2021, 06:07 PM |
Brunn Carsten | President and CEO | Oct 13, 2021 | Sale | $4.39 | 15,313 | 67,224 | 278,759 | Oct 15, 2021, 06:07 PM |
Brunn Carsten | President and CEO | Sep 02, 2021 | Sale | $4.51 | 4,523 | 20,399 | 229,372 | Sep 03, 2021, 04:18 PM |
BARABE TIMOTHY C | Director | Aug 18, 2021 | Buy | $4.00 | 9,000 | 36,000 | 190,013 | Aug 20, 2021, 06:09 PM |
BARABE TIMOTHY C | Director | Mar 26, 2021 | Buy | $4.10 | 10,000 | 41,000 | 181,013 | Mar 30, 2021, 04:50 PM |
TRABER PETER G | Chief Medical Officer | Mar 18, 2021 | Buy | $4.50 | 10,000 | 45,000 | 98,000 | Mar 19, 2021, 05:34 PM |
TRABER PETER G | Chief Medical Officer | Mar 17, 2021 | Buy | $4.53 | 10,000 | 45,295 | 88,000 | Mar 19, 2021, 05:34 PM |
Johnston Lloyd P. | COO and SVP, R&D | Mar 17, 2021 | Sale | $4.45 | 15,128 | 67,312 | 87,477 | Mar 19, 2021, 05:33 PM |
Brunn Carsten | President and CEO | Mar 02, 2021 | Sale | $4.26 | 5,461 | 23,257 | 216,826 | Mar 03, 2021, 05:21 PM |
Johnston Lloyd P. | COO and SVP, R&D | Feb 11, 2021 | Option Exercise | $0.63 | 44,871 | 28,269 | 102,605 | Feb 16, 2021, 06:10 PM |
TRABER PETER G | Chief Medical Officer | Dec 14, 2020 | Buy | $3.24 | 40,000 | 129,424 | 40,000 | Dec 16, 2020, 04:31 PM |
Brunn Carsten | President and CEO | Dec 02, 2020 | Sale | $3.35 | 3,323 | 11,134 | 101,350 | Dec 03, 2020, 04:22 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Oct 23, 2020 | Option Exercise | $2.77 | 30,000 | 83,100 | 126,149 | Oct 27, 2020, 05:13 PM |
SPRINGER TIMOTHY A | Director | Oct 22, 2020 | Buy | $2.63 | 1,770,204 | 4,656,699 | 13,486,460 | Oct 23, 2020, 05:12 PM |
SPRINGER TIMOTHY A | Director | Oct 21, 2020 | Buy | $2.50 | 880,000 | 2,199,472 | 11,716,256 | Oct 23, 2020, 05:12 PM |
SPRINGER TIMOTHY A | Director | Oct 23, 2020 | Buy | $2.71 | 994,488 | 2,699,737 | 14,480,948 | Oct 23, 2020, 05:12 PM |
SPRINGER TIMOTHY A | Director | Oct 20, 2020 | Buy | $2.21 | 910,000 | 2,013,193 | 10,836,256 | Oct 20, 2020, 06:07 PM |
SPRINGER TIMOTHY A | Director | Oct 19, 2020 | Buy | $2.36 | 759,500 | 1,795,002 | 9,926,256 | Oct 20, 2020, 06:07 PM |
SPRINGER TIMOTHY A | Director | Oct 16, 2020 | Buy | $2.42 | 218,196 | 528,034 | 9,166,756 | Oct 20, 2020, 06:07 PM |
SPRINGER TIMOTHY A | Director | Oct 09, 2020 | Buy | $2.00 | 276,703 | 552,465 | 8,948,560 | Oct 14, 2020, 04:18 PM |
SPRINGER TIMOTHY A | Director | Oct 07, 2020 | Buy | $1.65 | 654,953 | 1,078,577 | 8,141,416 | Oct 08, 2020, 05:50 PM |
SPRINGER TIMOTHY A | Director | Oct 06, 2020 | Buy | $1.68 | 2,000,000 | 3,365,800 | 7,486,463 | Oct 08, 2020, 05:50 PM |
SPRINGER TIMOTHY A | Director | Oct 08, 2020 | Buy | $1.89 | 530,441 | 1,000,836 | 8,671,857 | Oct 08, 2020, 05:50 PM |
BARABE TIMOTHY C | Director | Oct 06, 2020 | Buy | $1.68 | 50,000 | 83,985 | 171,013 | Oct 08, 2020, 04:25 PM |
Brunn Carsten | President and CEO | Sep 02, 2020 | Sale | $2.39 | 3,364 | 8,035 | 93,735 | Sep 03, 2020, 04:29 PM |
BARABE TIMOTHY C | Director | Jun 24, 2020 | Option Exercise | $1.46 | 32,840 | 47,946 | 121,013 | Jun 26, 2020, 04:21 PM |
Brunn Carsten | President and CEO | Jun 02, 2020 | Sale | $3.86 | 3,253 | 12,557 | 86,162 | Jun 03, 2020, 04:42 PM |
BARABE TIMOTHY C | Director | Mar 17, 2020 | Buy | $2.00 | 5,000 | 10,000 | 88,173 | Mar 19, 2020, 05:16 PM |
Brunn Carsten | President and CEO | Mar 03, 2020 | Sale | $3.86 | 3,374 | 13,011 | 78,477 | Mar 03, 2020, 04:25 PM |
Johnston Lloyd P. | COO and SVP, R&D | Jan 16, 2020 | Option Exercise | $0.47 | 5,128 | 2,410 | 16,734 | Jan 21, 2020, 05:21 PM |
BARABE TIMOTHY C | Director | Dec 23, 2019 | Option Exercise | $1.46 | 65,681 | 95,894 | 83,173 | Dec 26, 2019, 05:30 PM |
SPRINGER TIMOTHY A | Director | Dec 23, 2019 | Option Exercise | $1.46 | 3,940,887 | 5,753,695 | 5,486,463 | Dec 26, 2019, 05:30 PM |
COX CARRIE SMITH | Director | Dec 23, 2019 | Option Exercise | $1.46 | 65,681 | 95,894 | 65,681 | Dec 26, 2019, 05:30 PM |
Myers Scott Dunseth | Director | Dec 23, 2019 | Option Exercise | $1.46 | 39,409 | 57,537 | 80,845 | Dec 26, 2019, 05:29 PM |
Brunn Carsten | President and CEO | Dec 02, 2019 | Sale | $1.53 | 14,272 | 21,809 | 70,914 | Dec 03, 2019, 04:20 PM |
SPRINGER TIMOTHY A | Director | Aug 20, 2019 | Option Exercise | $1.81 | 1,100,000 | 1,991,000 | 1,545,576 | Aug 20, 2019, 04:33 PM |
SPRINGER TIMOTHY A | Director | Aug 20, 2019 | Option Exercise | $1.81 | 1,600,000 | 2,896,000 | 6,056,597 | Aug 20, 2019, 04:33 PM |
Smolinski Stephen | Chief Commercial Officer | Aug 20, 2019 | Option Exercise | $1.81 | 13,812 | 25,000 | 13,812 | Aug 20, 2019, 04:32 PM |
Myers Scott Dunseth | Director | Aug 20, 2019 | Option Exercise | $1.81 | 41,436 | 74,999 | 41,436 | Aug 20, 2019, 04:32 PM |
Kogan Elona Esq. | General Counsel | Aug 20, 2019 | Option Exercise | $1.81 | 82,872 | 149,998 | 182,872 | Aug 20, 2019, 04:32 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Aug 20, 2019 | Option Exercise | $1.81 | 50,000 | 90,500 | 86,114 | Aug 20, 2019, 04:31 PM |
Brunn Carsten | President and CEO | Aug 20, 2019 | Option Exercise | $1.81 | 41,436 | 74,999 | 41,436 | Aug 20, 2019, 04:31 PM |
ZENNER PATRICK J | Director | Aug 20, 2019 | Option Exercise | $1.81 | 55,248 | 99,999 | 55,248 | Aug 20, 2019, 04:29 PM |
SPRINGER TIMOTHY A | Director | Aug 14, 2019 | Buy | $1.74 | 10,000 | 17,415 | 86,418 | Aug 16, 2019, 04:18 PM |
BARABE TIMOTHY C | Director | Aug 13, 2019 | Buy | $1.72 | 10,000 | 17,200 | 17,492 | Aug 15, 2019, 04:19 PM |
Johnston Lloyd P. | COO and SVP, R&D | Jul 23, 2019 | Option Exercise | $0.47 | 10,000 | 4,700 | 11,606 | Jul 25, 2019, 04:15 PM |
Farokhzad Omid | Director | Jan 25, 2019 | Buy | $1.50 | 83,333 | 125,000 | 83,333 | Mar 29, 2019, 04:17 PM |
SPRINGER TIMOTHY A | Director | Jan 25, 2019 | Buy | $1.50 | 66,666 | 99,999 | 76,418 | Mar 29, 2019, 04:15 PM |
SPRINGER TIMOTHY A | Director | Jan 25, 2019 | Buy | $1.50 | 4,000,000 | 6,000,000 | 4,456,597 | Mar 29, 2019, 04:15 PM |
SPRINGER TIMOTHY A | Director | Nov 10, 2017 | Buy | $9.03 | 4,752 | 42,906 | 9,752 | Mar 29, 2019, 04:15 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Jan 07, 2019 | Option Exercise | $2.77 | 36,114 | 100,036 | 36,114 | Feb 21, 2019, 04:29 PM |
Nashat Amir | Director | Jan 25, 2019 | Buy | $1.50 | 1,166,666 | 1,749,999 | 2,676,234 | Jan 29, 2019, 04:37 PM |
Sands Earl | Chief Medical Officer | Nov 17, 2017 | Buy | $10.26 | 7,500 | 76,967 | 7,500 | Nov 21, 2017, 04:08 PM |
SPRINGER TIMOTHY A | Director | Nov 14, 2017 | Buy | $9.27 | 57,598 | 534,095 | 461,349 | Nov 16, 2017, 05:14 PM |
Abraham David | GC, CCO & Corporate Secretary | Nov 14, 2017 | Buy | $9.25 | 5,405 | 49,996 | 5,405 | Nov 14, 2017, 09:58 PM |
CAUTREELS WERNER | President and CEO | Nov 13, 2017 | Buy | $9.31 | 20,000 | 186,250 | 321,203 | Nov 14, 2017, 09:57 PM |
SPRINGER TIMOTHY A | Director | Nov 10, 2017 | Buy | $9.04 | 26,338 | 238,097 | 403,751 | Nov 13, 2017, 06:19 PM |
SPRINGER TIMOTHY A | Director | Nov 09, 2017 | Buy | $9.34 | 5,000 | 46,681 | 5,000 | Nov 13, 2017, 06:19 PM |
SPRINGER TIMOTHY A | Director | Nov 09, 2017 | Buy | $9.35 | 22,000 | 205,659 | 377,413 | Nov 13, 2017, 06:19 PM |
BARABE TIMOTHY C | Director | Nov 09, 2017 | Buy | $9.73 | 2,500 | 24,335 | 4,992 | Nov 13, 2017, 06:18 PM |
BARABE TIMOTHY C | Director | Nov 10, 2017 | Buy | $9.00 | 2,500 | 22,505 | 7,492 | Nov 13, 2017, 06:18 PM |
Nashat Amir | Director | Sep 26, 2017 | Sale | $18.91 | 70,226 | 1,328,079 | 1,550,478 | Sep 28, 2017, 05:10 PM |
Nashat Amir | Director | Sep 25, 2017 | Sale | $18.99 | 37,175 | 705,883 | 1,618,242 | Sep 26, 2017, 05:19 PM |
Nashat Amir | Director | Sep 22, 2017 | Sale | $19.26 | 42,036 | 809,781 | 1,654,114 | Sep 26, 2017, 05:19 PM |
Siewers David | CFO and Treasurer | Sep 20, 2017 | Option Exercise | $0.63 | 16,424 | 10,347 | 14,230 | Sep 22, 2017, 05:30 PM |
Siewers David | CFO and Treasurer | Sep 20, 2017 | Sale | $20.00 | 16,424 | 328,480 | 0 | Sep 22, 2017, 05:30 PM |
Nashat Amir | Director | Sep 21, 2017 | Sale | $19.86 | 104,577 | 2,076,826 | 1,694,676 | Sep 22, 2017, 04:09 PM |
Nashat Amir | Director | Sep 20, 2017 | Sale | $20.03 | 42,610 | 853,389 | 1,795,587 | Sep 22, 2017, 04:09 PM |
Johnston Lloyd P. | COO and SVP, R&D | Jun 15, 2017 | Option Exercise | $0.47 | 10,512 | 4,941 | 12,118 | Jul 10, 2017, 04:19 PM |
Johnston Lloyd P. | COO and SVP, R&D | Jun 15, 2017 | Sale | $17.04 | 10,512 | 179,141 | 1,606 | Jul 10, 2017, 04:19 PM |
Johnston Lloyd P. | COO and SVP, R*D | Jul 03, 2017 | Option Exercise | $2.77 | 5,959 | 16,506 | 7,565 | Jul 06, 2017, 04:05 PM |
Johnston Lloyd P. | COO and SVP, R*D | Jul 03, 2017 | Sale | $19.10 | 5,959 | 113,806 | 7,465 | Jul 06, 2017, 04:05 PM |
Siewers David | Chief Financial Officer | Jun 30, 2017 | Option Exercise | $0.63 | 7,420 | 4,675 | 7,420 | Jul 05, 2017, 12:00 AM |
Siewers David | Chief Financial Officer | Jun 30, 2017 | Sale | $20.00 | 7,420 | 148,405 | 0 | Jul 05, 2017, 12:00 AM |
Siewers David | Chief Financial Officer | Jun 29, 2017 | Option Exercise | $0.57 | 9,616 | 5,443 | 9,652 | Jun 30, 2017, 04:33 PM |
Siewers David | Chief Financial Officer | Jun 29, 2017 | Sale | $20.00 | 9,652 | 193,042 | 36 | Jun 30, 2017, 04:33 PM |
SPRINGER TIMOTHY A | Director | Jun 27, 2017 | Buy | $17.71 | 338,791 | 5,999,988 | 355,413 | Jun 28, 2017, 04:36 PM |
Keller Peter | Chief Business Officer | Jun 27, 2017 | Option Exercise | $0.63 | 4,595 | 2,895 | 5,000 | Jun 28, 2017, 04:35 PM |
Keller Peter | Chief Business Officer | Jun 27, 2017 | Sale | $19.30 | 4,595 | 88,681 | 405 | Jun 28, 2017, 04:35 PM |
Siewers David | Chief Financial Officer | Jun 26, 2017 | Sale | $20.00 | 6,886 | 137,720 | 36 | Jun 28, 2017, 04:35 PM |
Johnston Lloyd P. | COO and SVP, R*D | Jun 15, 2017 | Option Exercise | $0.47 | 20,512 | 9,641 | 22,118 | Jun 19, 2017, 04:12 PM |
Johnston Lloyd P. | COO and SVP, R*D | Jun 15, 2017 | Sale | $17.00 | 20,512 | 348,640 | 1,606 | Jun 19, 2017, 04:12 PM |
SPRINGER TIMOTHY A | Director | Jun 01, 2017 | Buy | $13.75 | 518 | 7,123 | 16,622 | Jun 02, 2017, 04:05 PM |
SPRINGER TIMOTHY A | Director | May 18, 2017 | Buy | $14.00 | 4,860 | 68,040 | 16,104 | May 19, 2017, 04:06 PM |
SPRINGER TIMOTHY A | Director | May 17, 2017 | Buy | $14.01 | 11,244 | 157,483 | 11,244 | May 19, 2017, 04:06 PM |
KANIA EDWIN M JR | Director | May 16, 2017 | Sale | $14.00 | 266,795 | 3,735,130 | 560,067 | May 16, 2017, 05:28 PM |
Johnston Lloyd P. | COO AND SVP, R&D | Apr 17, 2017 | Option Exercise | $0.39 | 13,205 | 5,150 | 14,811 | Apr 18, 2017, 05:18 PM |
Johnston Lloyd P. | COO AND SVP, R&D | Apr 17, 2017 | Sale | $13.95 | 13,205 | 184,210 | 1,606 | Apr 18, 2017, 05:18 PM |
Farokhzad Omid | Director | Mar 23, 2017 | Option Exercise | $3.92 | 60,000 | 235,108 | 188,004 | Mar 27, 2017, 04:02 PM |
Johnston Lloyd P. | COO AND SVP, R&D | Jan 23, 2017 | Option Exercise | $0.39 | 15,000 | 5,850 | 16,606 | Jan 30, 2017, 04:54 PM |
Johnston Lloyd P. | COO AND SVP, R&D | Jan 23, 2017 | Sale | $14.01 | 15,000 | 210,106 | 5,496 | Jan 30, 2017, 04:54 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Dec 28, 2016 | Option Exercise | $2.77 | 10,000 | 27,700 | 10,000 | Dec 30, 2016, 06:07 PM |
Kishimoto Takashi Kei | Chief Scientific Officer | Dec 28, 2016 | Sale | $17.55 | 10,000 | 175,500 | 0 | Dec 30, 2016, 06:07 PM |
Abraham David | CCO, Gen.Counsel, Corp.Sec. | Dec 21, 2016 | Option Exercise | $0.47 | 12,280 | 5,772 | 14,844 | Dec 23, 2016, 02:19 PM |
Abraham David | CCO, Gen.Counsel, Corp.Sec. | Dec 21, 2016 | Sale | $18.00 | 14,844 | 267,192 | 0 | Dec 23, 2016, 02:19 PM |
Keller Peter | Chief Business Officer | Dec 19, 2016 | Sale | $18.58 | 4,723 | 87,753 | 405 | Dec 21, 2016, 07:14 PM |
ORBIMED ADVISORS LLC | Director | Jun 27, 2016 | Buy | $14.00 | 550,000 | 7,700,000 | 1,825,415 | Jun 29, 2016, 08:55 PM |
RUSNANO | 10% Owner | Jun 27, 2016 | Buy | $14.00 | 107,143 | 1,500,002 | 157,009 | Jun 29, 2016, 06:14 PM |
GORDON CARL L | Director | Jun 27, 2016 | Buy | $14.00 | 550,000 | 7,700,000 | 1,825,415 | Jun 29, 2016, 04:49 PM |
ORBIMED ADVISORS LLC | Director | Jun 27, 2016 | Buy | $14.00 | 550,000 | 7,700,000 | 1,825,415 | Jun 29, 2016, 04:49 PM |
Osage University Partners II, L.P. | 10% Owner | Jun 27, 2016 | Buy | $14.00 | 350,000 | 4,900,000 | 862,543 | Jun 29, 2016, 04:47 PM |
Nanodimension Management Ltd | 10% Owner | Jun 27, 2016 | Buy | $14.00 | 385,000 | 5,390,000 | 1,045,957 | Jun 29, 2016, 04:46 PM |
TAS Partners, LLC | Director | Jun 27, 2016 | Buy | $14.00 | 710,000 | 9,940,000 | 1,237,028 | Jun 29, 2016, 04:45 PM |
Nashat Amir | Director | Jun 27, 2016 | Buy | $14.00 | 150,000 | 2,100,000 | 1,836,703 | Jun 29, 2016, 04:45 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Jun 27, 2016 | Buy | $14.00 | 150,000 | 2,100,000 | 1,836,703 | Jun 29, 2016, 04:44 PM |
Owner | Relationship | Date | Value($) |
SPRINGER TIMOTHY A | Director | 03/18/2024 | 488 |
SPRINGER TIMOTHY A | Director | 02/07/2024 | 1,575 |
SPRINGER TIMOTHY A | Director | 03/15/2024 | 672 |
SPRINGER TIMOTHY A | Director | 02/06/2024 | 520 |
SPRINGER TIMOTHY A | Director | 03/14/2024 | 1,061 |
SPRINGER TIMOTHY A | Director | 01/17/2024 | 552 |
SPRINGER TIMOTHY A | Director | 03/13/2024 | 1,868 |
SPRINGER TIMOTHY A | Director | 03/12/2024 | 735 |
SPRINGER TIMOTHY A | Director | 03/11/2024 | 785 |
SPRINGER TIMOTHY A | Director | 03/08/2024 | 3,187 |
SPRINGER TIMOTHY A | Director | 03/26/2024 | 2,876,847 |
SPRINGER TIMOTHY A | Director | 03/18/2024 | 11,398 |
SPRINGER TIMOTHY A | Director | 03/14/2024 | 351,677 |
SPRINGER TIMOTHY A | Director | 03/15/2024 | 314,545 |
Brunn Carsten | President and CEO | 11/13/2023 | 1,073,517 |
SPRINGER TIMOTHY A | Director | 11/15/2023 | 49,999,835 |
SPRINGER TIMOTHY A | Director | 11/15/2023 | 9,999,967 |
Brunn Carsten | President and CEO | 09/25/2023 | 3,108 |
TRABER PETER G | Chief Medical Officer | 09/25/2023 | 747 |
Brunn Carsten | President and CEO | 01/04/2023 | 31,287 |
Brunn Carsten | President and CEO | 01/05/2023 | 15,214 |
Johnston Lloyd P. | Chief Operations Officer | 01/04/2023 | 7,247 |
Johnston Lloyd P. | Chief Operations Officer | 01/05/2023 | 3,830 |
Kishimoto Takashi Kei | Chief Scientific Officer | 01/05/2023 | 3,830 |
Kishimoto Takashi Kei | Chief Scientific Officer | 01/04/2023 | 7,247 |
TRABER PETER G | Chief Medical Officer | 01/05/2023 | 3,913 |
TRABER PETER G | Chief Medical Officer | 01/04/2023 | 9,273 |
Brunn Carsten | President and CEO | 12/05/2022 | 6,014 |
Brunn Carsten | President and CEO | 09/28/2022 | 4,470 |
Brunn Carsten | President and CEO | 09/02/2022 | 8,810 |
COX CARRIE SMITH | Director | 06/13/2022 | 149,799 |
BARABE TIMOTHY C | Director | 05/09/2022 | 38,720 |
BARABE TIMOTHY C | Director | 01/14/2022 | 21,000 |
TRABER PETER G | Chief Medical Officer | 01/05/2022 | 9,955 |
Kishimoto Takashi Kei | Chief Scientific Officer | 01/05/2022 | 10,541 |
Johnston Lloyd P. | Chief Operations Officer | 01/05/2022 | 10,541 |
Brunn Carsten | President and CEO | 01/05/2022 | 41,959 |
SPRINGER TIMOTHY A | Director | 12/15/2021 | 631,099 |
TRABER PETER G | Chief Medical Officer | 12/10/2021 | 12,196 |
Kishimoto Takashi Kei | Chief Scientific Officer | 12/10/2021 | 13,053 |
Johnston Lloyd P. | Chief Operations Officer | 12/10/2021 | 13,053 |
Brunn Carsten | President and CEO | 12/10/2021 | 51,363 |
SPRINGER TIMOTHY A | Director | 12/13/2021 | 43,491 |
SPRINGER TIMOTHY A | Director | 12/10/2021 | 175,439 |
SPRINGER TIMOTHY A | Director | 12/09/2021 | 11,468,880 |
Tan Kevin | Chief Financial Officer | 12/02/2021 | 15,127 |
DeSilva Nishan M | Director | 12/02/2021 | 20,723 |
COX CARRIE SMITH | Director | 12/03/2021 | 50,664 |
Brunn Carsten | President and CEO | 12/02/2021 | 14,065 |
TRABER PETER G | Chief Medical Officer | 10/13/2021 | 15,962 |
Kishimoto Takashi Kei | Chief Scientific Officer | 10/13/2021 | 17,086 |
Johnston Lloyd P. | Chief Operations Officer | 10/13/2021 | 17,086 |
Brunn Carsten | President and CEO | 10/13/2021 | 67,224 |
Brunn Carsten | President and CEO | 09/02/2021 | 20,399 |
BARABE TIMOTHY C | Director | 08/18/2021 | 36,000 |
BARABE TIMOTHY C | Director | 03/26/2021 | 41,000 |
TRABER PETER G | Chief Medical Officer | 03/18/2021 | 45,000 |
TRABER PETER G | Chief Medical Officer | 03/17/2021 | 45,295 |
Johnston Lloyd P. | COO and SVP, R&D | 03/17/2021 | 67,312 |
Brunn Carsten | President and CEO | 03/02/2021 | 23,257 |
Johnston Lloyd P. | COO and SVP, R&D | 02/11/2021 | 28,269 |
TRABER PETER G | Chief Medical Officer | 12/14/2020 | 129,424 |
Brunn Carsten | President and CEO | 12/02/2020 | 11,134 |
Kishimoto Takashi Kei | Chief Scientific Officer | 10/23/2020 | 83,100 |
SPRINGER TIMOTHY A | Director | 10/22/2020 | 4,656,699 |
SPRINGER TIMOTHY A | Director | 10/21/2020 | 2,199,472 |
SPRINGER TIMOTHY A | Director | 10/23/2020 | 2,699,737 |
SPRINGER TIMOTHY A | Director | 10/20/2020 | 2,013,193 |
SPRINGER TIMOTHY A | Director | 10/19/2020 | 1,795,002 |
SPRINGER TIMOTHY A | Director | 10/16/2020 | 528,034 |
SPRINGER TIMOTHY A | Director | 10/09/2020 | 552,465 |
SPRINGER TIMOTHY A | Director | 10/07/2020 | 1,078,577 |
SPRINGER TIMOTHY A | Director | 10/06/2020 | 3,365,800 |
SPRINGER TIMOTHY A | Director | 10/08/2020 | 1,000,836 |
BARABE TIMOTHY C | Director | 10/06/2020 | 83,985 |
Brunn Carsten | President and CEO | 09/02/2020 | 8,035 |
BARABE TIMOTHY C | Director | 06/24/2020 | 47,946 |
Brunn Carsten | President and CEO | 06/02/2020 | 12,557 |
BARABE TIMOTHY C | Director | 03/17/2020 | 10,000 |
Brunn Carsten | President and CEO | 03/03/2020 | 13,011 |
Johnston Lloyd P. | COO and SVP, R&D | 01/16/2020 | 2,410 |
BARABE TIMOTHY C | Director | 12/23/2019 | 95,894 |
SPRINGER TIMOTHY A | Director | 12/23/2019 | 5,753,695 |
COX CARRIE SMITH | Director | 12/23/2019 | 95,894 |
Myers Scott Dunseth | Director | 12/23/2019 | 57,537 |
Brunn Carsten | President and CEO | 12/02/2019 | 21,809 |
SPRINGER TIMOTHY A | Director | 08/20/2019 | 1,991,000 |
SPRINGER TIMOTHY A | Director | 08/20/2019 | 2,896,000 |
Smolinski Stephen | Chief Commercial Officer | 08/20/2019 | 25,000 |
Myers Scott Dunseth | Director | 08/20/2019 | 74,999 |
Kogan Elona Esq. | General Counsel | 08/20/2019 | 149,998 |
Kishimoto Takashi Kei | Chief Scientific Officer | 08/20/2019 | 90,500 |
Brunn Carsten | President and CEO | 08/20/2019 | 74,999 |
ZENNER PATRICK J | Director | 08/20/2019 | 99,999 |
SPRINGER TIMOTHY A | Director | 08/14/2019 | 17,415 |
BARABE TIMOTHY C | Director | 08/13/2019 | 17,200 |
Johnston Lloyd P. | COO and SVP, R&D | 07/23/2019 | 4,700 |
Farokhzad Omid | Director | 01/25/2019 | 125,000 |
SPRINGER TIMOTHY A | Director | 01/25/2019 | 99,999 |
SPRINGER TIMOTHY A | Director | 01/25/2019 | 6,000,000 |
SPRINGER TIMOTHY A | Director | 11/10/2017 | 42,906 |
Kishimoto Takashi Kei | Chief Scientific Officer | 01/07/2019 | 100,036 |
Nashat Amir | Director | 01/25/2019 | 1,749,999 |
Sands Earl | Chief Medical Officer | 11/17/2017 | 76,967 |
SPRINGER TIMOTHY A | Director | 11/14/2017 | 534,095 |
Abraham David | GC, CCO & Corporate Secretary | 11/14/2017 | 49,996 |
CAUTREELS WERNER | President and CEO | 11/13/2017 | 186,250 |
SPRINGER TIMOTHY A | Director | 11/10/2017 | 238,097 |
SPRINGER TIMOTHY A | Director | 11/09/2017 | 46,681 |
SPRINGER TIMOTHY A | Director | 11/09/2017 | 205,659 |
BARABE TIMOTHY C | Director | 11/09/2017 | 24,335 |
BARABE TIMOTHY C | Director | 11/10/2017 | 22,505 |
Nashat Amir | Director | 09/26/2017 | 1,328,079 |
Nashat Amir | Director | 09/25/2017 | 705,883 |
Nashat Amir | Director | 09/22/2017 | 809,781 |
Siewers David | CFO and Treasurer | 09/20/2017 | 10,347 |
Siewers David | CFO and Treasurer | 09/20/2017 | 328,480 |
Nashat Amir | Director | 09/21/2017 | 2,076,826 |
Nashat Amir | Director | 09/20/2017 | 853,389 |
Johnston Lloyd P. | COO and SVP, R&D | 06/15/2017 | 4,941 |
Johnston Lloyd P. | COO and SVP, R&D | 06/15/2017 | 179,141 |
Johnston Lloyd P. | COO and SVP, R*D | 07/03/2017 | 16,506 |
Johnston Lloyd P. | COO and SVP, R*D | 07/03/2017 | 113,806 |
Siewers David | Chief Financial Officer | 06/30/2017 | 4,675 |
Siewers David | Chief Financial Officer | 06/30/2017 | 148,405 |
Siewers David | Chief Financial Officer | 06/29/2017 | 5,443 |
Siewers David | Chief Financial Officer | 06/29/2017 | 193,042 |
SPRINGER TIMOTHY A | Director | 06/27/2017 | 5,999,988 |
Keller Peter | Chief Business Officer | 06/27/2017 | 2,895 |
Keller Peter | Chief Business Officer | 06/27/2017 | 88,681 |
Siewers David | Chief Financial Officer | 06/26/2017 | 137,720 |
Johnston Lloyd P. | COO and SVP, R*D | 06/15/2017 | 9,641 |
Johnston Lloyd P. | COO and SVP, R*D | 06/15/2017 | 348,640 |
SPRINGER TIMOTHY A | Director | 06/01/2017 | 7,123 |
SPRINGER TIMOTHY A | Director | 05/18/2017 | 68,040 |
SPRINGER TIMOTHY A | Director | 05/17/2017 | 157,483 |
KANIA EDWIN M JR | Director | 05/16/2017 | 3,735,130 |
Johnston Lloyd P. | COO AND SVP, R&D | 04/17/2017 | 5,150 |
Johnston Lloyd P. | COO AND SVP, R&D | 04/17/2017 | 184,210 |
Farokhzad Omid | Director | 03/23/2017 | 235,108 |
Johnston Lloyd P. | COO AND SVP, R&D | 01/23/2017 | 5,850 |
Johnston Lloyd P. | COO AND SVP, R&D | 01/23/2017 | 210,106 |
Kishimoto Takashi Kei | Chief Scientific Officer | 12/28/2016 | 27,700 |
Kishimoto Takashi Kei | Chief Scientific Officer | 12/28/2016 | 175,500 |
Abraham David | CCO, Gen.Counsel, Corp.Sec. | 12/21/2016 | 5,772 |
Abraham David | CCO, Gen.Counsel, Corp.Sec. | 12/21/2016 | 267,192 |
Keller Peter | Chief Business Officer | 12/19/2016 | 87,753 |
ORBIMED ADVISORS LLC | Director | 06/27/2016 | 7,700,000 |
RUSNANO | 10% Owner | 06/27/2016 | 1,500,002 |
GORDON CARL L | Director | 06/27/2016 | 7,700,000 |
ORBIMED ADVISORS LLC | Director | 06/27/2016 | 7,700,000 |
Osage University Partners II, L.P. | 10% Owner | 06/27/2016 | 4,900,000 |
Nanodimension Management Ltd | 10% Owner | 06/27/2016 | 5,390,000 |
TAS Partners, LLC | Director | 06/27/2016 | 9,940,000 |
Nashat Amir | Director | 06/27/2016 | 2,100,000 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 06/27/2016 | 2,100,000 |
Period of Report: 06/30/2023
10-K/10-Q Filings: View